Literature DB >> 2082657

Histogenesis of sarcomatous component of the gliosarcoma: an ultrastructural study.

K L Ho1.   

Abstract

This report describes the ultrastructural findings of the sarcomatous component in five cases of gliosarcoma. The tumor contained a heterogenous population of cells with collagen scattered in the interstitium. Three main cell types were found: histiocyte-like cells, fibroblast-like cells and undifferentiated cells. The histiocyte-like cells had oval nuclei, short and flat rough endoplasmic reticulum, prominent Golgi apparatus, lysosomes, phagocytic vacuoles, ruffled cytoplasmic membrane with filopodia, segmental basal lamina and occasional intercellular junctions. The fibroblast-like cells had elongated nuclei, prominent cisterns of rough endoplasmic reticulum and microfilaments. The undifferentiated cell cytoplasmic processes suggesting differentiation toward histiocyte-like cell. In addition, intermediate cells, myofibroblasts, multinucleated giant cells and xanthomatous cells were also present. Occasional glial processes were interposed between tumor cells. Some were enclosed by cytoplasmic processes of histiocyte-like cells and others engulfed within the cytoplasm. Capillary showed surface infoldings, fenestrations of endothelial cells, thickened basal lamina, occasional pericytes and scattered collagen. Some capillaries were surrounded by aggregating histiocyte-like cells and undifferentiated cells. The present findings suggest that (a) the sarcomatous component in gliosarcoma is likely derived from undifferentiated cells with a broad differentiation into histiocytic, fibroblastic and other cell types, (b) endothelial cells and pericytes may not participate in sarcomatous development, (c) capillaries within the sarcomatous component are of non-gliomatous type, and (d) the histiocyte-like cells are capable of phagocytizing glial elements.

Entities:  

Mesh:

Year:  1990        PMID: 2082657     DOI: 10.1007/BF00334506

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  45 in total

Review 1.  Vascular structures in brain tumors.

Authors:  A Hirano; T Matsui
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

2.  Malignant fibrous histiocytoma. An electron microscopic study.

Authors:  J B Taxy; H Battifora
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

3.  The ultrastructural spectrum of malignant fibrous histiocytoma.

Authors:  R Lagacé
Journal:  Ultrastruct Pathol       Date:  1987       Impact factor: 1.094

4.  Establishment and characterization of neoplastic cells from a malignant fibrous histiocytoma. A possible stem cell line.

Authors:  K Shirasuna; M Sugiyama; T Miyazaki
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

5.  Intracerebral malignant fibrous histiocytoma: a light and electron microscopic study with immunohistochemistry.

Authors:  R H Simpson; J I Phillips; P Miller; D Hagen; J E Anderson
Journal:  Clin Neuropathol       Date:  1986 Sep-Oct       Impact factor: 1.368

6.  Immunohistochemical investigation of collagen subtypes in human glioblastomas.

Authors:  W Paulus; W Roggendorf; D Schuppan
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

7.  Malignant fibrous histiocytoma tumor cells resemble fibroblasts.

Authors:  G S Wood; J H Beckstead; R R Turner; M R Hendrickson; R L Kempson; R A Warnke
Journal:  Am J Surg Pathol       Date:  1986-05       Impact factor: 6.394

8.  Gliosarcoma: a histologic and immunohistochemical reaffirmation.

Authors:  J M Meis; K L Ho; J S Nelson
Journal:  Mod Pathol       Date:  1990-01       Impact factor: 7.842

9.  Clinical and pathological study of 24 cases of gliosarcoma.

Authors:  R A Morantz; I Feigin; J Ransohoff
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

10.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA.

Authors:  E R WEIBEL; G E PALADE
Journal:  J Cell Biol       Date:  1964-10       Impact factor: 10.539

View more
  9 in total

1.  Gliofibroma: immunohistochemical analysis.

Authors:  R Schober; C Bayindir; A Canbolat; H Urich; W Wechsler
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Intradural primary chondroblastic osteosarcoma: case report.

Authors:  M T Walker; L R Toye; S W Coons; R W Porter; R C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

3.  Anaplastic pleomorphic xanthoastrocytoma.

Authors:  C Bayindir; N Balak; A Karasu; D Kasaroğlu
Journal:  Childs Nerv Syst       Date:  1997-01       Impact factor: 1.475

4.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 5.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Distribution of p53 protein expression in gliosarcomas: an immunohistochemical study.

Authors:  S Albrecht; J H Connelly; J M Bruner
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Interphase cytogenetics of glioblastoma and gliosarcoma.

Authors:  W Paulus; A Bayas; G Ott; W Roggendorf
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Primary osteosarcoma of the cerebrum with immunohistochemical and ultrastructural studies: report of a case.

Authors:  N Ohara; K Hayashi; C Shinohara; M Kamitani; T Furuta; T Yoshino; K Takahashi; K Taguchi; T Akagi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  Prognostic factors among single primary gliosarcoma cases: A study using Surveillance, Epidemiology, and End Results data from 1973-2013.

Authors:  Bin Chen; Bin Liu; Chao Wu; Zhenyu Wang
Journal:  Cancer Med       Date:  2019-08-28       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.